Dupont Capital Management Corp Novavax Inc Transaction History

Dupont Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$121.0 - $257.67 $512,435 - $1.09 Million	-4,235 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$112.98 - $319.93 $162,804 - $461,019	-1,441 Reduced 25.39%	4,235 $768,000
Q4 2020 Jan 28, 2021	BUY	$78.74 - $139.5 $41,495 - $73,516	527 Added 10.23%	5,676 $633,000
Q3 2020 Oct 29, 2020	BUY	$79.44 - $178.51 $409,036 - $919,147	5,149 New	5,149 $558,000
Q2 2020 Jul 24, 2020	SELL	$13.86 - $83.61 $246,846 - $1.49 Million	-17,810 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$3.93 - $16.0 $69,993 - $284,960	17,810 New	17,810 $242,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.